QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,448 signal articles · 89 in last 24h · 107,773 total before filter · latest 34m ago
89last 24h
2566last 7d
492● bullish (7d)
237● bearish (7d)
201publishers
AllMacro219Earnings1598M&A122Regulatory16Product10Analyst25
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How Xeltis Partnership And Kidney Care Initiatives Could Shape DaVita’s (DVA) Long-Term Care Strategy
Simply Wall St.10d agobullish
How Xeltis Partnership And Kidney Care Initiatives Could Shape DaVita’s (DVA) Long-Term Care Strategy

Xeltis recently secured an additional €20.5 million in funding led by Horizon 3 Healthcare, with DaVita participating to help advance the aXess™ vascular access platform through US trials, regulatory submissions, and European rollout. Alongside this investment, investor attention has intensified around DaVita’s upcoming August 2026 earnings report and its initiatives to expand equitable access to kidney care, including home dialysis and transplant support. With DaVita’s recent returns in...

How Investors Are Reacting To Deckers (DECK) Upgraded 2027 Guidance And Teva Product Expansion
Simply Wall St.10d agobullish
How Investors Are Reacting To Deckers (DECK) Upgraded 2027 Guidance And Teva Product Expansion

Earlier this month, Deckers Outdoor reported first-quarter 2026 sales of US$1,019.53 million with net income of US$129.97 million, and raised its full-year fiscal 2027 guidance to net sales of US$5.86–5.91 billion, operating margin slightly above 21.5%, and diluted EPS of US$7.35–7.50, assuming share repurchases equal to roughly 80% of projected free cash flow. Alongside the guidance upgrade, Deckers’ Teva division rolled out an extensive Fall 2026 performance and lifestyle lineup, including...

Bloomberg10d agobullish
Wall Street Picks AI Winners and Losers as Credit Swaps Surge

(Bloomberg) -- As Big Tech barrels toward trillions of dollars of planned spending on AI, a key cog in credit markets is showing signs of pressure. That, in turn, is lifting the cost of financing artificial intelligence while offering an early look at potential winners and losers.Most Read from BloombergUS Intercepts Iran Attack on Bases, Puncturing Days of CalmSK Hynix Profit Disappoints, Spending Soars to $31 BillionApple Set to Make Big Smart Home Push With Siri AI at CenterNvidia’s $750 Bill

Seagate Technology delivers Q4 beat as AI demand supports storage outlook
Proactive10d agobullish
Seagate Technology delivers Q4 beat as AI demand supports storage outlook

Seagate Technology Holdings PLC (NASDAQ:STX) shares rose about 2% on Wednesday after the data storage company reported fiscal fourth quarter results that exceeded Wall Street expectations on both earnings and revenue and issued guidance that pointed to continued momentum. For the quarter...

Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street
Barrons.com10d agobullish
Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.